1. ABOUT GARDP FOUNDATION
The Global Antibiotic Research & Development Partnership (GARDP Foundation) is a not-for[1]profit global health organization registered in Geneva, Switzerland. GARDP’s mission is to accelerate the development and access of treatments for drug-resistant bacterial infections. It does so by forging public-private partnerships all over the world to develop and expand access to treatments for serious bacterial infections and sepsis in adults, children and newborns, as well as sexually transmitted infections (STIs).

GARDP Foundation responds to the crisis in antimicrobial resistance. In 2015, the World Health Assembly, the decision-making body of the World Health Organization (WHO), adopted the Global Action Plan on Antimicrobial Resistance. The following year, to deliver on this plan, WHO and the Drugs for Neglected Diseases initiative created GARDP. In 2018, the GARDP Foundation was legally established as an independent entity.

Since then, GARDP Foundation has developed a portfolio of antibiotic treatments that targets WHO priority pathogens, priority diseases and key populations/regions that are especially affected by drug resistance. It is also pioneering new access initiatives with innovator, manufacturing and distribution partners. As of 2024, the GARDP team consists of about 100 people who collectively share extensive cross-sector R&D and access experience. They work with the key public and private sector stakeholders and partners, such as the research and development community, donors, industry and implementing countries.

2. PROJECT BACKGROUND & PURPOSE OF THE RFP

This RFP is focused on Pharmacovigilance services throughout the projects duration, from the initial phase (Safety Regulatory Information, submission capability, etc.), to its running part (expedited reporting, aggregate reporting) and closure (Final Listings).

Those services should be provided for:

• Clinical Trials (Phases I to IV)
• Pre-approval programs (e.g. managed access program

3. CRITERIA FOR SELECTING SUPPLIERS

The decision to award any contract as a result of this RFP process will be based on Suppliers’ responses and any subsequent negotiations or discussions. The decision-making process will consider the ability of each supplier to fulfil GARDP Foundation’s requirements as outlined within this RFP and the total cost of the offer.

Proposals will be assessed against, but not limited to, the following criteria:

Technical criteria:

Technical criteria will weigh a maximum of 70% of the award decision. They include technical expertise, project experience, team structure, project plan proposal, project management capabilities, client recommendations, values and cultural fit.

Financial criteria:

Financial criteria will weigh a minimum of 30% of the award decision. They include supplier competitiveness and the completeness of the offer, payment schedule based on deliverables, and a special discount for not-for-profit organizations.

Proposals evaluation and bid defense meeting:

Based on a pre-aligned selection grid, the GARDP Foundation selection committee will evaluate all written proposals to determine which suppliers shall be invited to a virtual meeting with the GARDP Foundation selection committee.

The duration of each meeting will be around 1 hour, including follow-up questions and answers. Agenda and potential questions will be shared in advance, together with the invitation to participate.

Value-add and insight:

Please list/describe any additional services that you feel would benefit GARDP Foundation and their associated costs (if any).

If you are interested to receive the complete documentation, please review, complete and sign that attached confidential framework and send it to: RFP_Procurement@gardp.org.

Due/closing date: May 9th 2025